| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.01 | 0.8 |